D
35
-6
CMCSA
50
6
MS
76
2
OXY
42
2
CTAS
43
3
TAP
37
8
XEL
41
4
LB
33
2
GRMN
45
8
ACN
54
-2
AMGN
38
4
CNP
52
3
PPL
57
2
HPQ
37
2
ECL
62
5
WM
60
3
KMX
38
-9
PSX
25
-12
DLTR
58
-5
FCX
75
3
D
35
-6
CMCSA
50
6
MS
76
2
OXY
42
2
CTAS
43
3
TAP
37
8
XEL
41
4
LB
33
2
GRMN
45
8
ACN
54
-2
AMGN
38
4
CNP
52
3
PPL
57
2
HPQ
37
2
ECL
62
5
WM
60
3
KMX
38
-9
PSX
25
-12
DLTR
58
-5
FCX
75
3
Financhill
Back

State Street SPDR S&P Regional Banking ETF Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Buy
64

KRE
State Street SPDR S&P Regional Banking ETF

Last Price:
$67.02
Seasonality Move:
-0.22%
Buy
60

ZBIO
Zenas BioPharma, Inc.

Last Price:
$41.35
Seasonality Move:
0.59%
Buy
64
State Street SPDR S&P Regional Banking ETF (KRE) is a Buy

Is State Street SPDR S&P Regional Banking ETF a Buy, Sell or Hold?

  • The current State Street SPDR S&P Regional Banking ETF [KRE] share price is $67.15. The Score for KRE is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • KRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Zenas BioPharma, Inc. (ZBIO) is a Buy

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $42.33. The Score for ZBIO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ZBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KRE Stock Price Chart

What is State Street SPDR S&P Regional Banking ETF's stock price today?

  • The State Street SPDR S&P Regional Banking ETF share price today is $67.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRE is experiencing slight selling pressure.

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $42.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

KRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.53 Buy
Relative Strength Index (14 RSI): 68.41 Buy
Chaikin Money Flow: -1616122 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.42 - 67.06) Buy
Bollinger Bands (100): (60.35 - 65.33) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.47 Buy
Relative Strength Index (14 RSI): 61.08 Buy
Chaikin Money Flow: 587345 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.32 - 39.82) Buy
Bollinger Bands (100): (17.72 - 34.64) Buy

KRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 67.24 Sell
20-day SMA: 65.36 Buy
50-day SMA: 62.45 Buy
200-day SMA: 60.1 Buy
8-day EMA: 66.91 Buy
20-day EMA: 65.47 Buy
50-day EMA: 62.72 Buy
200-day EMA: 40.27 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.46 Buy
20-day SMA: 37.97 Buy
50-day SMA: 33.51 Buy
200-day SMA: 18.21 Buy
8-day EMA: 24.11 Buy
20-day EMA: 12.41 Buy
50-day EMA: 5.54 Buy
200-day EMA: 1.47 Buy

State Street SPDR S&P Regional Banking ETF Earnings Growth & KRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

State Street SPDR S&P Regional Banking ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):